Cholecystitis

2 papers1 finding

Human trial1
Humans1

Associations

1

Ondansetron

upin humans1HR 1.697

1 study

Ondansetron raises the risk of cholecystitis in humans (HR=1.697, 95% CI 1.322-2.177, p<0.0001).
“cholecystitis (HR=1.697, 95% CI 1.322-2.177, p<0.0001)”
Humans12 months
Concurrent Ondansetron Use during Semaglutide Initiation Is Associated with Increased Biliary Complications in a Large Real-World Cohort
ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Ondansetron

Trial sponsors

Hallym University Kangnam Sacred Heart Hospital
1 trialPhase 460 people
Chonbuk National University Hospital
1 trialPhase 1529 people

Latest

3 in 12 months

American Journal of Cancer Research11 Sep

Serum inflammatory markers and influencing factors in patients with colorectal adenomas

Case-control study of 420 peopleBiomarkers

RMD Open25 Aug

Metabolic effects of GLP-1 receptor agonists in rheumatology patients and inflammatory outcomes: a single-centre retrospective cohort

Cohort study of 119 peopleGLP-1 receptor agonists

ADA Scientific Sessions 2026 Abstract5 Jun

Concurrent Ondansetron Use during Semaglutide Initiation Is Associated with Increased Biliary Complications in a Large Real-World Cohort

Cohort study of 33,152 peoplePopulations

ADA Scientific Sessions 2025 Abstract13 Jun

Integrated Diabetes Care Improves Metabolic Outcomes and Promotes Utilization of Incretin Analogs and Sodium–Glucose Cotransporter Type 2 Inhibitors in Patients with Serious Mental Illness

Non-randomised trial in 68 peopleSGLT2 inhibitors